PL337940A1 - Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma - Google Patents

Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma

Info

Publication number: PL337940A1
Authority: PL; Poland
Prior art keywords: prostaglandines; exhibiting; derivatives; useful; side effects
Prior art date: 1997-07-11

Application number

PL98337940A

Inventor

Johan Stjernschantz

Bahram Resul

Staffan Lake

Original Assignee

Pharmacia & Upjohn Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-11

Filing date

1998-07-10

Publication date

2000-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL337940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-10 Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab

2000-09-11 Publication of PL337940A1 publication Critical patent/PL337940A1/en

Links

208000010412 Glaucoma Diseases 0.000 title 1
230000000694 effects Effects 0.000 title 1
230000001747 exhibiting effect Effects 0.000 title 1
125000003259 prostaglandin group Chemical group 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL98337940A 1997-07-11 1998-07-10 Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma PL337940A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9702706A SE9702706D0 (en)	1997-07-11	1997-07-11	Prostaglandin derivatives devoid of side effects for the treatment of glaucoma

Publications (1)

Publication Number	Publication Date
PL337940A1 true PL337940A1 (en)	2000-09-11

Family

ID=20407743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL98337940A PL337940A1 (en)	1997-07-11	1998-07-10	Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma

Country Status (18)

Country	Link
EP (1)	EP1014991A1 (en)
JP (1)	JP2002509543A (en)
KR (1)	KR20010021682A (en)
CN (1)	CN1169528C (en)
AU (1)	AU739828B2 (en)
BR (1)	BR9815501A (en)
CA (1)	CA2294779A1 (en)
HU (1)	HUP0003106A3 (en)
IL (1)	IL133871A (en)
IS (1)	IS5333A (en)
NO (1)	NO20000062D0 (en)
NZ (1)	NZ501834A (en)
PL (1)	PL337940A1 (en)
RU (1)	RU2207858C2 (en)
SE (1)	SE9702706D0 (en)
SK (1)	SK183499A3 (en)
TR (1)	TR200000008T2 (en)
WO (1)	WO1999002165A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9803761D0 (en) *	1998-11-04	1998-11-04	Synphora Ab	Method to avoid increased iridial pigmentation during prostaglandin treatment
WO2000051980A1 (en)	1999-03-05	2000-09-08	The Procter & Gamble Company	C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en)	1999-08-04	2005-05-17	The Procter & Gamble Company	2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en)	2000-03-31	2002-11-21	Delong Michell Anthony	Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en)	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en)	2000-03-31	2002-03-28	Delong Mitchell Anthony	Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6531504B2 (en) *	2001-05-17	2003-03-11	Allergan, Inc.	Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en)	2001-05-24	2001-07-18	Resolution Chemicals Ltd	Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) *	2001-06-26	2004-03-30	Allergan, Inc.	Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
WO2004031142A2 (en) *	2002-09-16	2004-04-15	Texas Tech University System	Inhibition of metallo-beta-lactamase
US7091231B2 (en) *	2004-12-10	2006-08-15	Allergan, Inc.	12-Aryl prostaglandin analogs
GB0501192D0 (en)	2005-01-20	2005-03-02	Resolution Chemicals Ltd	Stable prostaglandin-containing compositions
PL212658B1 (en) *	2005-04-18	2012-11-30	Inst Farmaceutyczny	Method for obtaining the derivatives of 13,14-dihydro-PGF₂α
US8455513B2 (en)	2007-01-10	2013-06-04	Aerie Pharmaceuticals, Inc.	6-aminoisoquinoline compounds
US20110038884A1 (en)	2008-04-28	2011-02-17	National University Co., Hamamatsu Univer. School Of Medicine	Immunopotentiating agent comprising ep1 agonist
US8450344B2 (en)	2008-07-25	2013-05-28	Aerie Pharmaceuticals, Inc.	Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2834451T3 (en)	2009-05-01	2021-06-17	Aerie Pharmaceuticals Inc	Dual Mechanism Inhibitors for Treating Diseases
US8901319B2 (en)	2009-10-16	2014-12-02	Cayman Chemical Company, Incorporated	Process for the preparation of F-series prostaglandins
PL2831077T3 (en)	2012-03-28	2016-10-31		Bicyclic pyrazinone derivatives
JP2012246301A (en) *	2012-08-10	2012-12-13	Cayman Chemical Co Inc	Method for preparing prostaglandins f
EP2976080B1 (en)	2013-03-15	2019-12-25	Aerie Pharmaceuticals, Inc.	Conjugates of isoquinoline compounds and prostaglandins
US9643927B1 (en)	2015-11-17	2017-05-09	Aerie Pharmaceuticals, Inc.	Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (en)	2016-08-31	2019-07-08	Aerie Pharmaceuticals Inc	OPHTHALMIC COMPOSITIONS.
JP2020515583A (en)	2017-03-31	2020-05-28	アエリエファーマシューティカルズインコーポレイテッド	Aryl cyclopropyl-amino-isoquinolinyl amide compound
AU2019337703B2 (en)	2018-09-14	2023-02-02	Aerie Pharmaceuticals, Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4085272A (en) *	1977-03-30	1978-04-18	American Cyanamid Company	11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives
US4132738A (en) *	1978-02-23	1979-01-02	Miles Laboratories, Inc.	Preparation of 15-deoxy-16-hydroxyprostaglandins
US4311707A (en) *	1979-02-12	1982-01-19	American Cyanamid Company	Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
EP0664707B1 (en) *	1992-10-13	1997-06-04	Alcon Laboratories, Inc.	Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma

1997
- 1997-07-11 SE SE9702706A patent/SE9702706D0/en unknown
1998
- 1998-07-10 CA CA002294779A patent/CA2294779A1/en not_active Abandoned
- 1998-07-10 CN CNB988070456A patent/CN1169528C/en not_active Ceased
- 1998-07-10 SK SK1834-99A patent/SK183499A3/en unknown
- 1998-07-10 NZ NZ501834A patent/NZ501834A/en unknown
- 1998-07-10 PL PL98337940A patent/PL337940A1/en unknown
- 1998-07-10 EP EP98934082A patent/EP1014991A1/en not_active Ceased
- 1998-07-10 JP JP50856099A patent/JP2002509543A/en not_active Withdrawn
- 1998-07-10 AU AU83683/98A patent/AU739828B2/en not_active Ceased
- 1998-07-10 TR TR2000/00008T patent/TR200000008T2/en unknown
- 1998-07-10 WO PCT/SE1998/001368 patent/WO1999002165A1/en not_active Ceased
- 1998-07-10 HU HU0003106A patent/HUP0003106A3/en unknown
- 1998-07-10 BR BR9815501-6A patent/BR9815501A/en not_active IP Right Cessation
- 1998-07-10 KR KR1020007000240A patent/KR20010021682A/en not_active Ceased
- 1998-07-10 IL IL13387198A patent/IL133871A/en not_active IP Right Cessation
- 1998-07-10 RU RU2000103224/14A patent/RU2207858C2/en not_active IP Right Cessation
2000
- 2000-01-06 NO NO20000062A patent/NO20000062D0/en unknown
- 2000-01-07 IS IS5333A patent/IS5333A/en unknown

Also Published As

Publication number	Publication date
SE9702706D0 (en)	1997-07-11
KR20010021682A (en)	2001-03-15
NZ501834A (en)	2002-05-31
AU8368398A (en)	1999-02-08
TR200000008T2 (en)	2000-05-22
HUP0003106A3 (en)	2002-12-28
NO20000062L (en)	2000-01-06
IL133871A0 (en)	2001-04-30
EP1014991A1 (en)	2000-07-05
RU2207858C2 (en)	2003-07-10
SK183499A3 (en)	2000-07-11
NO20000062D0 (en)	2000-01-06
CA2294779A1 (en)	1999-01-21
IL133871A (en)	2004-09-27
BR9815501A (en)	2001-07-17
HUP0003106A2 (en)	2001-01-29
WO1999002165A1 (en)	1999-01-21
CN1169528C (en)	2004-10-06
JP2002509543A (en)	2002-03-26
HK1029942A1 (en)	2001-04-20
AU739828B2 (en)	2001-10-18
IS5333A (en)	2000-01-07
CN1262623A (en)	2000-08-09

Publication	Publication Date	Title
PL337940A1 (en)	2000-09-11	Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma
IS1995B (en)	2005-03-15	Triazole derivatives, useful in treatment
GB2319250B (en)	1999-01-27	Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
EP0728749A3 (en)	1997-02-26	Triazine derivatives, their preparation and use
PL336290A1 (en)	2000-06-19	Sulphonamides for treating endothelin-involving disorders
GB9823873D0 (en)	1998-12-30	2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
CY2596B2 (en)	2010-03-03	Antivirally active heterocyclic azahexane derivatives
IL126095A0 (en)	1999-05-09	Azolobenzazepine derivatives as neurogically active agents
HU9800138D0 (en)	1998-03-30	8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
AU4133096A (en)	1996-05-23	Taxoid derivatives, their preparation and their use as antitumor agents
HUP9900790A3 (en)	2001-11-28	Imidazoquinazoline derivatives
EP1007028A4 (en)	2002-06-05	8-iso-prostaglandins for glaucoma therapy
PL330277A1 (en)	1999-05-10	Derivatives of 2,4-diaminopyrimidine
HU9601565D0 (en)	1996-08-28	N-acyl-(2-aryl-cyclopropyl-methyl)-amine derivatives
IL137518A0 (en)	2001-07-24	Derivatives of 1,2,4-oxadiazolone
PL341318A1 (en)	2001-04-09	Derivatives of indole useful in treating oesteoporosis
HUP9801565A3 (en)	2001-11-28	Benzimidazole derivatives
HUP0001792A3 (en)	2001-10-29	Dibenzo-oxazepine and-dioxepine derivatives and their use as anti-tumor agents
GB9405400D0 (en)	1994-05-04	Taxane derivatives
AU3564597A (en)	1998-02-09	Transmitter-receiver pair
GB2296239B (en)	1998-08-26	Taxane derivatives
EP0910356A4 (en)	2002-02-13	Biphenylamido derivatives as melatonergic agents
GB9508748D0 (en)	1995-06-14	Benzimidazole derivatives
AU7799898A (en)	1998-12-30	Compositions and methods for treating glaucoma
AU9160498A (en)	1999-02-16	Use of sulfated glycosaminoglycans for treating of retinopathy